FeesSafety
Pluang+

First Graphene secures first sports footwear order with US brand Flux Footwear for graphene-enhanced shoes.

Market News
07 Oct 2026, 02:00 WIB
PRNewsWire
View Source
Bullish
First Graphene secures first sports footwear order with US brand Flux Footwear for graphene-enhanced shoes.

First Graphene Limited has secured its first purchase order from US-based Flux Footwear to supply PureGRAPH® graphene material for Flux's athletic and leisure shoes. This marks First Graphene's entry into the global sports footwear market, valued at over US$150 billion, expanding from its previous work in industrial and safety footwear. The graphene-enhanced shoes will benefit from improved durability, abrasion resistance, and performance, aligning with growing consumer demand for longer-lasting, high-performance footwear. This order establishes a commercial pathway for recurring revenue and expands First Graphene's presence in the US market.

The story on First Graphene Limited's PureGRAPH® production order provides context for readers interested in consumer cyclical stocks. For readers following this sector, here is Pluang's market snapshot as of Oct 07, 2026 05:51 WIB: Out of 112 priced US consumer cyclical stocks, 69 rose and 41 fell today. Among notable movers, Lennar Corporation (LEN) rose 4.37% to USD 77.69 with a typical hold time of 67 days and a Pluang order activity of 77% Buy, contrasting with Abercrombie & Fitch Co. (ANF) which rose 4.09% to USD 141.47 but had 84% Sell orders. Carnival Corp (CCL) gained 3.99% to USD 26.58 with a 100% Buy order activity and a longer typical hold time of 106 days.

More News

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
47 minutes ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
1 hour ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
2 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
2 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 in early November 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 in early November 2026

Rexel Développement SAS announced it bought back a total of 3,878 of its own shares between November 9 and 13, 2026, at an average price of €34.67 per share. This share repurchase is part of the authorization granted by its shareholders to operate on...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App